Clinical Trial: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901595) titled 'Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes' on Oct. 22.

Brief Summary: This is a Phase 1/2 randomized study of oral doses of PAL-119 in healthy volunteers and participants with diabetes.

Study Start Date: Nov. 01

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers and Diabetes Participants

Intervention: DRUG: PAL-119

Small synthetic molecule

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Paulex Bio Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....